Precigen Inc (PGEN)
1.385
-0.02
(-1.07%)
USD |
NASDAQ |
May 17, 16:00
1.385
0.00 (0.00%)
After-Hours: 20:00
Precigen Total Assets (Quarterly): 134.85M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 134.85M |
| December 31, 2023 | 151.04M |
| September 30, 2023 | 190.69M |
| June 30, 2023 | 207.53M |
| March 31, 2023 | 241.55M |
| December 31, 2022 | 215.98M |
| September 30, 2022 | 259.24M |
| June 30, 2022 | 321.22M |
| March 31, 2022 | 335.57M |
| December 31, 2021 | 359.86M |
| September 30, 2021 | 376.90M |
| June 30, 2021 | 402.57M |
| March 31, 2021 | 406.98M |
| December 31, 2020 | 314.59M |
| September 30, 2020 | 336.19M |
| June 30, 2020 | 361.72M |
| March 31, 2020 | 404.67M |
| December 31, 2019 | 455.76M |
| September 30, 2019 | 604.90M |
| June 30, 2019 | 655.19M |
| March 31, 2019 | 709.86M |
| December 31, 2018 | 716.18M |
| September 30, 2018 | 980.42M |
| Date | Value |
|---|---|
| June 30, 2018 | 825.15M |
| March 31, 2018 | 895.67M |
| December 31, 2017 | 846.85M |
| September 30, 2017 | 898.26M |
| June 30, 2017 | 933.99M |
| March 31, 2017 | 915.93M |
| December 31, 2016 | 949.07M |
| September 30, 2016 | 1.006B |
| June 30, 2016 | 1.031B |
| March 31, 2016 | 962.43M |
| December 31, 2015 | 982.05M |
| September 30, 2015 | 989.89M |
| June 30, 2015 | 792.94M |
| March 31, 2015 | 819.99M |
| December 31, 2014 | 576.27M |
| September 30, 2014 | 538.50M |
| June 30, 2014 | 500.54M |
| March 31, 2014 | 547.81M |
| December 31, 2013 | 469.47M |
| September 30, 2013 | 474.20M |
| June 30, 2013 | 283.45M |
| March 31, 2013 | 199.68M |
| December 31, 2012 | 151.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
134.85M
Minimum
Mar 2024
655.19M
Maximum
Jun 2019
336.85M
Average
335.88M
Median
Total Assets (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.805M |
| HealthEquity Inc | 3.164B |
| Corvus Pharmaceuticals Inc | 40.08M |
| Oragenics Inc | 4.966M |
| MAIA Biotechnology Inc | 8.716M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.83M |
| Shareholders Equity (Quarterly) | 97.02M |
| Current Ratio | 1.722 |
| Net Debt Paydown Yield | 2.38% |